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Abstract
Background: Recently, we introduced a novel peptide nucleic acid (PNA) multi-probe real time PCR method
targeting the hsp65 gene (hsp65 PNA RT-PCR) to distinguish Mycobacterium abscessus groups.
Methods: Here, we evaluated the usefulness of the hsp65 PNA RT-PCR for the direct identification of the M.
abscessus group at the subspecies and genotype levels from sputa samples. The method was applied to total sputa
DNA from 60 different patients who were identified as having mycobacterial infections via rpoB PCR restriction
analysis of the same cultures.
Results: The hsp65 PNA RT-PCR method had higher sensitivity than the multi-probe real-time PCR assay targeting
hsp65 (HMPRT-PCR) for the detection of M. abscessus from sputum [96.7 % (29/30 samples) vs. 70 % (21/30 samples);
100 % specificity].
Conclusions: These results suggest that the PNA-based method is feasible for the detection of M. abscessus members
not only from cultures but also directly from sputa.
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Background
The Mycobacterium abscessus complex represents a group
of rapidly growing mycobacteria (RGM) that account for
approximately 65–80 % of RGM pulmonary infections [1].
In Korea, the incidence of M. abscessus lung diseases has
been increasing; these infections account for 70–80 % of
RGM-induced lung diseases [2–5].
The taxonomic status of the M. abscessus group re-
mains undetermined. Recent advances in taxonomic ap-
proaches revealed that the M. abscessus group could be
further divided into three closely related taxa [i.e., M.
abscessus subsp. abscessus (hereafter referred to as M.
abscessus), M. abscessus subsp. massiliense (hereafter re-
ferred to as M. massiliense) and M. abscessus subsp.
bolletii (hereafter referred to as M. bolletii)] [6–8]. Re-
cently, it was reported that M. massiliense could be fur-
ther subdivided into two genotypes (hereafter referred to
as Type I and Type II) based on hsp65 sequence analysis.
All of the strains belonging to Type II are distinct in
Korean patients due to a rough colony morphotype
without any exceptions [9]. A recent complete genome
study revealed that the rough colony phenotype of the
Type II strains may be due to a large deletion event in
the glycopeptidolipid (GPL)-related genes [10, 11]. Fur-
thermore, a recent report based on pulsed-field gel elec-
trophoresis (PFGE) and multi-locus sequence typing
(MLST) also revealed taxonomic separation between M.
massiliense Type II-1 and Type II-2 [12].
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M. massiliense has been increasingly recognized as an
emerging pathogen that causes postsurgical wound in-
fection outbreaks [13]. Recently, it was identified as the
causative agent of respiratory outbreaks in two cystic fi-
brosis centers and showed evidence of patient-to-patient
transmission [14, 15]. Infections with the M. abscessus
group are difficult to treat, because these mycobacteria
exhibit intrinsic resistance to various antibiotics. Suscep-
tibility to clarithromycin (CLA) varies among members
of the M. abscessus group; for example, while the major-
ity of M. abscessus and M. bolletii exhibit resistance to
CLA, M. massiliense is susceptible. Resistance is charac-
terized by the presence of the erm(41) gene that encodes
the erythromycin ribosomal methylases (ERM) [16].
Despite their close genetic relatedness, disparities in
pathogenic potential, transmission mode, and antibiotic
susceptibility were found among members of the M.
abscessus group. Therefore, accurate identification of
members of the M. abscessus group is important for pa-
tient treatment and epidemiological purposes [17].
Peptide nucleic acids (PNAs) are artificially synthesized
DNA analogues with an uncharged peptide backbone.
PNAs have more favorable hybridization properties and
chemical, thermal, and biological stability due to their un-
charged nature and peptide bond-linked backbone [18].
Due to these favorable characteristics, PNA has been widely
applied as a diagnostic tool in molecular biology [19]. A
PNA probe-based real-time PCR assay has been developed
for mycobacteria diagnosis, particularly for the simultan-
eous separation of M. tuberculosis and NTM in clinical
specimens [20, 21]. Recently, we introduced a novel peptide
nucleic acid (PNA) multi-probe real- time PCR method
that targeted the hsp65 gene (hsp65 PNA RT-PCR) to dis-
tinguish between the four types within the M. abscessus
groups [M. abscessus and the 3M. massiliense types (Type
I, Type II-1 and Type II-2)] using 3 PNA probes. For this
evaluation, we applied 27 reference strains and 228 clinical
isolates belonging to the M. abscessus groups. With the ex-
ception of one clinical isolate, most of the samples (227/
228 isolates, 99.6 % sensitivity) were clearly separated at the
subspecies or genotype levels, thereby demonstrating the
technique’s feasibility for the detection of M. abscessus at
the mycobacterial culture level. To the best of our know-
ledge, this was the first report to use a PNA- based multi-
probe approach for bacterial diagnosis [22].
The aim of this study was to evaluate the usefulness of
the hsp65 PNA RT-PCR in directly identifying the M.
abscessus group at the subspecies or genotype levels
from sputum samples. We applied the technique to spu-
tum DNA samples from 60 different patients who were
previously diagnosed with mycobacterial infections via
rpoB PCR restriction analysis of the same cultures (30
samples were culture positive for M. abscessus complex
strains, and 30 samples were culture positive for other
mycobacteria). These results were compared with the re-
sults from the multi-probe real-time PCR assay targeting
hsp65 (HMPRT-PCR) that was previously developed by
our laboratory [23].
Methods
Mycobacterial strains and sputum samples
Six mycobacteria reference strains including 5 strains be-
longing to the M. abscessus group (M. abscessus ATCC
19977T, M. bolletii CIP 108541T, M. massiliense Type I
KCTC 19086T, M. massiliense Type II-1 SNUMC 50594
and M. massiliense Type II-2 SNUMC 53618) and M.
tuberculosis H37Rv ATCC 27294T, and 60 sputum speci-
mens suspected of harboring mycobacterial infection
were used in this study. Four of the 6 mycobacterial ref-
erence strains were provided by the Korean Institute of
Tuberculosis (KIT). M. massiliense Type II-1 SNUMC
50594 and M. massiliense Type II-2 SNUMC 53618 were
provided by the Seoul National University College of
Medicine (SNUMC). Sixty sputum samples from differ-
ent patients with positive AFB smears detected between
April 01, 2008, and July 31, 2008, at AMC, Seoul, Re-
public of Korea, were included in this study. Identifica-
tion of mycobacterial infections in all sputum samples
(30 samples were culture positive for M. abscessus com-
plex strains and 30 samples were culture positive for
other mycobacteria) was previously determined by rpoB
PRA analysis of the same cultures. The sputa were
digested, decontaminated, and concentrated as recom-
mended by the WHO [24]. The processed sediment was
stained using the Ziehl–Neelsen method. The results of
the AFB smears were graded according to the recom-
mendations of the American Thoracic Society and the
Center for Disease Control and Prevention [25]. Sputa
with trace AFB smear results (1–2 bacilli in 300 fields)
were also included in this study. The protocol for this
study including the documentation for waiver of informed
consent was approved by the institutional review board of
Seoul National University Hospital (C-1503-058-655) and
Asan Medical Center (AMC IRB 2007–0331).
DNA extraction
Chromosomal DNA was extracted from the sputum sam-
ples using the bead beater–phenol extraction method as
previously described [26].
hsp65 PNA RT-PCR
For the detection of M. abscessus from sputum samples,
the hsp65 PNA RT-PCR method was applied to 60 spu-
tum DNA samples, as previously described [22]. Briefly, a
total of three reporter dyes were used for the specific sim-
ultaneous detection of the four types of the M. abscessus
group (M. abscessus, Type I, Type II-1, and Type II-2) in a
single reaction.: FAM for the detection of M. abscessus
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and M. massiliense at the species level, Hex for the dis-
crimination of M. massiliense Type I and Type II, and
Texas Red for the discrimination of M. massiliense Type
II-1 and Type II-2. The sequences of the probes and
primers are provided in Table 1. The probes were pur-
chased from Panagene (Daejeon, Korea) and the primers
from Macrogen (Seoul, Korea). A LightCycler (version 96;
Roche Life Science, Mannheim, Germany) system was
used for the real-time PCR, and three channels were used
for the experiment. The optimal reaction mixture was
established for the sensitive and specific detection of target
sequences. A 10 μl reaction mixture was prepared for each
sample as follows: 1 μl PCR reaction buffer for FastStart
Taq (Roche), 2 mM MgCl2, 2 μl GC-RICH solution
(Roche), 0.2 mM deoxynucleoside triphosphate mixture
(Roche), 1 μM forward primer (Abs/Mas-F, 5′-CCGA
GACGCTGCTGAAGAG-3′), 0.3 μM reverse primer
(Abs/Mas-R, 5′-GACGTCCTCGGCGATGAT-3′), 0.4 μM
PNA FAM probe (Mas/Abs, 5′-Dabcyl-CCTCGTTAC
CAACCT-O-K-FAM-3′), 0.15 μM PNA Hex probe (Mas-
T2, 5′-Dabcyl-GGAGATTCCGGCC-O-K-Hex-3′), 0.5 μM
PNA Texas Red probe (Mas-T2-1), 0.4 U FastStart Taq
(Roche), 0.1 mg/ml bovine serum albumin (New England
Biolabs), 2 μl template DNA, and distilled water (Roche).
The cycling conditions were 300 s at 95 °C and 45 cycles of
20 s at 95 °C, 15 s at 62 °C (single acquisition of fluores-
cence signals), and 40 s at 74 °C. Melting curve analysis was
performed using the following cycles: 120 s at 95 °C and
180 s at 37 °C with a ramping speed of 1.1 °C/s. Then, the
temperature was increased from 37 °C to 80 °C at a
temperature transition rate of 0.07 °C/s during which time
the fluorescence signal was continuously acquired. Dupli-
cate experiments were performed to determine the melting
temperatures of the probes designed for the target M.
abscessus group by real-time PCR, and DNA from a total
of 60 sputum samples (Additional file 1) was subsequently
tested for species identification by Tm analysis.
HMPRT-PCR
The HMPRT-PCR was applied to the same 60 sputum
DNA samples as previously described for comparison with
the hsp65 PNA RT-PCR [23]. Briefly, a total of 4 channels
(CH.) were used for probes specific for 7 mycobacteria spe-
cies: CH. 610 for the detection of M. tuberculosis, CH. 640
for the detection of M. kansasii, M. intracellulare, and M.
fortuitum-peregrinum complex, CH. 670 for the detection
of M. avium, and CH. 705 for the detection of M. absces-
sus and M. massiliense. A LightCycler 2.0 system was used
for the real- time PCR. The LC Faststart DNA Master HP
kit (Roche Diagnostics) was used for the preparation of the
mastermix according to the kit protocol. A 10 μl reaction
mixture was prepared for each sample as follows: 1 μl Taq
buffer (containing dNTP mix and 10 mM MgCl2), an
additional 2 mM MgCl2, 0.4 μM NTM-specific forward
primer (HSP-NTM-F, 5′-CCGYTGCTGGAGAAGGTCA
TYCAG-3′), 0.3 μM TBC-specific forward primer (HSP-
TBC-F, 5′-CGCTGCTCGAGAAGGTCATCGGA-3′), 1 μM
mycobacteria-specific reverse primer (HSP-MYC-R, 5′-
CGATGATGGTGGTCTCGTCCTTGGT-3′), 0.2 μM
HybProbes, template (2 μl of culture-extracted DNA or
4 μl of sputum-extracted DNA with 0.1 mg/ml BSA
(NEB)) and sterile distilled water. The cycling conditions
were as follows: 10 min at 95 °C and 45 cycles of 10 s at
95 °C, 20 s at 65 °C (single acquisition of fluorescence sig-
nals) and 20 s at 72 °C. The cycling was followed by melt-
ing curve analysis: 10 s at 95 °C and 30 s at 57 °C. The
temperature was increased from 57 °C to 90 °C with a
temperature transition rate of 0.1 °C/s and the continuous
acquisition of the fluorescence signal.
Results
Application of hsp65 PNA RT-PCR to 30 sputum samples
previously demonstrated to be infected by the
M. abscessus group
To evaluate the usefulness of hsp65 PNA RT-PCR for
the direct detection of M. abscessus group infection from
sputa DNA, we tested a total of 30 sputum DNA sam-
ples from different patients previously diagnosed with
infection by the M. abscessus group via rpoB PCR re-
striction analysis of the same cultures. The hsp65 PNA
RT-PCR method enabled the identification of 29 out of
30 sputum samples (96.7 %) into 18M. abscessus and 11
Table 1 Primers and PNA probes used for identification of Mycobacterium abscessus group in the present study
Primer/Probe Sequence (5′→ 3′) Tm (°C)
a Potential target organisms
Primer
Abs/Mas-F CCGAGACGCTGCTGAAGAG 66.2 M. abscessus, M. massiliense
Abs/Mas-R GACGTCCTCGGCGATGAT 65.5 M. abscessus, M. massiliense
PNA Probe
Mas/Abs Dabcyl-CCTCGTTACCAACCT-O-K-FAMb 66.8 M. massiliense, M. abscessus
Mas-T2 Dabcyl-GGAGATTCCGGCC-O-K-Hex 69.5 M. massiliense Type 2/Type 1
Mas-T2-1 Dabcyl-CTGAATTACCTTCTC-O-K-Texas Red 62.0 M. massiliense Type 2-1/Type 2-2
aPrimer Tm was calculated by using Oligo software V 6.50 and probe Tm was calculated by http://pnabio.com/support/PNA_Tool.htm; Tm, melting temperature
bK, lysine; O, O linker
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M. massiliense strains. The assay was also able to differ-
entiate all 11M. massiliense strains into three genotypes:
Type I (5 sputa), Type II-1 (4 sputa) and Type II-2 (2 sputa)
(Fig. 1a-c, Table 2 and Additional file 1).
To verify the consistency of our hsp65 PNA RT-PCR
method in a clinical setting, we analyzed the range of
Tms of the clinical samples at the intra-subspecies or
intra-genotypic level in each channel. In the FAM chan-
nel, differences in Tms among the 18M. abscessus spu-
tum samples and 11M. massiliense strains were 2.9 °C
(49.0–52.3 °C) and 0.7 °C (61.4–62.1 °C), respectively,
which was less than the inter-subspecies Tms differences
between M. abscessus and M. massiliense (11.5–11.9 °C).
In the Hex channel, differences in Tms among the 4M.
massiliense Type I and 6M. massiliense Type II sputum
samples were 1.0 °C (60.0–61.0 °C) and 1.1 °C (68.5–
69.6 °C), respectively, which was less than the inter-
subspecies Tms difference between M. massiliense Type I
and Type II (8.8–9.1 °C). In the Texas Red channel, the
differences in Tms among the 4M. massiliense Type II-1
and 2M. massiliense Type II-2 sputum samples were
1.9 °C (51.5–53.4 °C) and 0.3 °C (46.4–46.7 °C), respect-
ively, which was less than the inter-genotypic Tms differ-
ence between M. massiliense Type II-1 and Type II-2
(4.8–7 °C) (Table 3). These results demonstrate the suit-
ability of the hsp65 PNA RT-PCR for the separation of
the M. abscessus group into subspecies or genotypes in
clinical settings.
Application of hsp65 PNA RT-PCR to 30 sputum samples
previously demonstrated to be infected by mycobacteria
other than the M. abscessus group
To validate the specificity of the hsp65 PNA RT-PCR
method in detecting M. abscessus group infections from
sputum samples, we applied the technique to 30 sputum
samples from different patients previously identified as in-
fected with mycobacteria other than the M. abscessus
group (10 patients with M. tuberculosis, 9 with M. avium,
7 with M. intracellulare, 1 with M. celatum, 1 with M.
fortuitum, 1 with M. kansasii and 1 with M. szulgai) via
rpoB PCR restriction analysis of the same cultures. None
of the 30 sputum DNA samples produced a detectable Tm
Fig. 1 Melting curve analysis of the hsp65 PNA real-time PCR of 60 sputa samples. M. abscessus and M. massiliense were differentially identified in
the FAM channel (a), M. massiliense Type I and II in the HEX channel (b), and M. massiliense Type II-1 and II-2 in the Texas Red channel (c). Sputa
including samples infected with non-M. abscessus group mycobacteria did not produce any significant melting peaks for the identification of the
M. abscessus group genotypes in any of the three channels (d)
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in the FAM channel that was specific for M. abscessus
group species detection, thereby validating the high speci-
ficity of the hsp65 PNA RT-PCR method for the detection
of the M. abscessus group from sputum samples. Only one
sputum sample (M. fortuitum) formed an insignificant Tm
in the Hex channel (Fig. 1d).
Comparison of hsp65 PNA RT-PCR versus HMPRT-PCR for
the direct detection of the M. abscessus group from
sputum samples
Previously, we introduced a multiprobe real-time PCR
assay targeting hsp65 (HMPRT-PCR) to detect and iden-
tify pathogenic mycobacteria directly from sputum speci-
mens. In this study, we compared the 2 methods (hsp65
PNA RT-PCR and HMPRT-PCR) for the direct detection
of the M. abscessus group from sputum samples. When
the 2 methods were applied to the same 30 sputum DNA
samples, the results showed that the hsp65 PNA RT-PCR
had higher sensitivity compared to the HMPRT-PCR in
detecting M. abscessus from sputum [96.7 % (29/30 sam-
ples) vs. 70 % (21/30samples)] (Table 2). A discrepancy be-
tween the two methods was found in nine samples. One
sputum sample (S1380) identified as M. massiliense Type
II-1 infection by hsp65 PNA RT-PCR was identified as M.
avium infection by HMPRT-PCR; its culture identification
was confirmed to be a coinfection of M. abscessus and M.
avium. HMPRT-PCR failed to detect M. abscessus in this
coinfection. Another sample (S1479) identified as M. mas-
siliense Type II-2 infection by hsp65 PNA RT-PCR was
identified as a coinfection of M. massiliense and M. avium
HMPRT-PCR; its culture identification was M. abscessus
infection. HMPRT-PCR could not detect 5 samples identi-
fied as M. abscessus infections by hsp65 PNA RT-PCR or
two samples identified as M. massiliense Type I and Type
II-1 infections by hsp65 PNA RT-PCR (Additional file 1).
Discussion
Recently, we reported that phylogenetic analysis based
on the sequence of the 604-bp hsp65 gene enabled taxo-
nomic separation among members of the M. abscessus
groups at the genotype and subspecies levels despite
representing a single target gene [9]. We also reported
that the separation of members of the M. abscessus
group based on pulsed-field gel electrophoresis (PFGE)
and multi-locus sequence typing (MLST) was nearly in
agreement with the results obtained using sequence-
based phylogenetic analysis of the 604-bp hsp65 gene
[12], which resulted in the phylogenetic separation of
four members of the M. abscessus groups [M. abscessus
and the three types of M. massiliense (I, II-1 and II-2)].
SNPs have been widely used for the diagnostic target-
ing of pathogens [27, 28] and human diseases [29]. For
use in bacterial identification, an SNP should show not
only intra-species or genotypic conservation but also
Table 2 Comparison of identification results between sputum
hsp65 PNA real-time PCR and sputum HMPRT-PCR based on
same culture-based rpoB PRA
rpoB PRA HMPRT-PCR hsp65 PNA
real-time PCR
Sensitivity
M. abscessus 30 14 18
M. massiliense NA 7 11
M. massiliense Type I NA NA 5
M. massiliense Type II-1 NA NA 4
M. massiliense Type II-2 NA NA 2
Total No. of identification 21 (70 %) 29 (97 %)
No. of misidentification 0 0
Specificity
Non-M. abscessus group 30 28 0
M. abscessus group
identified
0 (100 %) 0 (100 %)
No. of misidentification 0 NA
NA, not available
Table 3 Measurement of melting temperatures of M. abscessus
group from sputa samples by hsp65 PNA real-time PCR
Channels
Species FAM Hex Texas Red
M. abscessus
No. of identification 18 18 18
Average Tm (°C)
b 50.0 ± 0.85 59.7 ± 0.37 47.1 ± 0.45
Range of Tm (°C) 49.0–52.3 59.0–60.5 46.3–47.7
No. of failed detection 0 0 3
M. massiliense Type I
No. of identification 5 5 5
Average Tm (°C) 61.8 ± 0.37 60.6 ± 0.56 46.9 ± 0.28
Range of Tm (°C) 61.4–62.1 59.9–61.0 46.5–47.2
No. of failed detection 0 0 0
M. massiliense Type II-1
No. of identification 4 4 4
Average Tm (°C) 61.9 ± 0.08 69.1 ± 0.49 52.7 ± 0.89
Range of Tm (°C) 62.0–63.3 68.4–71.3 51.5–53.4
No. of failed detection 0 0 0
M. massiliense Type II-2
No. of identification 2 2 2
Average Tm (°C) 62.0 ± 0.07 69.0 ± 0.42 46.6 ± 0.21
Range of Tm (°C) 61.9–62.0 68.7–69.3 46.4–46.7
No. of failed detection 0 0 0
amean ± SD
b Tm, melting temperature; boldface, species specific Tm; −, no significant Tm
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inter-species or genotypic variation. Notably, there are
several SNPs in the 604-bp hsp65 sequence that are po-
tential targets of diagnostic methods for the separation
of members of M. abscessus. In a previous study, we de-
veloped an hsp65 PNA RT-PCR targeting three signature
SNPs in the 604-bp hsp65 gene that enabled the separ-
ation of the four types of M. abscessus (M. abscessus and
three types of M. massiliense) at the cultured isolate
level. The intra-genotypic conservation and inter-
genotypic variation for each SNP of members of the M.
abscessus group were confirmed by successful separation
in 227 out of 228 clinical isolates (99.6 %) [22]. In this
study, the application of the hsp65 PNA RT-PCR
method to sputum samples demonstrated that this
method could directly identify members of the M.
abscessus group at the subspecies or genotypic level
from sputum samples with 96.7 % sensitivity (29/30
samples) and 100 % specificity (Table 2), thereby demon-
strating its feasibility in identifying the M. abscessus
group not only from cultured isolates but also directly
from sputum samples.
PNA-based molecular beacons were reported to be su-
perior to conventional molecular probes due to their fas-
ter hybridization kinetics, high signal to background
ratio and improved specificity [30]. Indeed, PNAs have
been successfully applied for the highly sensitive detec-
tion of anthrax DNA and HIV RNA [31, 32]. PNA-based
molecular beacons were reported to be advantageous for
genotyping short sequences when high sequence specifi-
city was required. The typing of an SNP with DNA
probes such as the TaqMan or LightCycler probes
(which are usually at least 23 nucleotides in length) can
be problematic due to the limited discriminating power
of long DNA probes. PNA molecular probes are signifi-
cantly shorter than the TaqMan or LightCycler probes,
making probe design and genotype discrimination easier
[33]. Despite the short sequence length (13–15 bp) of
the probes, our hsp65 PNA RT-PCR could be success-
fully applied to the separation of members of the M.
abscessus group from sputum samples (Table 1) as well
as clinical isolates [22]. The presence of a mismatch in a
PNA/DNA duplex is reported to be more destabilizing
than a mismatch in a DNA/DNA duplex, suggesting that
the use of PNA probes may lead to more pronounced
difference in the average Tm in SNP detection compared
to the use of DNA probes [34]. In this study, our PNA
probes showed relatively large differences (4.8 °C to
11.9 °C) in Tms in SNP detection despite one nucleotide
mismatch. Thus, our probes provided improved discrim-
inative power for the separation of members of the M.
abscessus group compared to DNA probes, which are
always higher compared to the probes used for intra-
subspecies or intra-genotype analyses. This result dem-
onstrates the feasibility and reproducibility of our hsp65
PNA RT-PCR method in a clinical setting. The compari-
son of hsp65 PNA RT-PCR versus HMPRT-PCR in this
study demonstrated the higher sensitivity of the former
compared to the latter [96.7 % (29/30 samples) vs. 70 %
(21/30 samples)] in detecting M. abscessus from sputum
samples. These findings strongly support the hypothesis
that PNA-probe based technology may be superior to
technologies based on other probes (i.e., FRET-based
dual probes for the direct detection of mycobacteria
from sputum samples).
Notably, the Tms measured from sputum samples
showed small decreasing shifts (1–2.7 °C) compared to
our previously reported Tms of clinical isolates of the M.
abscessus genotypes [22] without compromising the dis-
crimination of the genotypes. This outcome may be due
to the presence of PCR-inhibitory substances in the
DNA extracts from the sputum specimens because in-
hibitory substances can cause Tm shifts [35, 36].
Conclusions
In conclusion, our data suggest that the hsp65 PNA RT-
PCR method developed in the previous study may repre-
sent a promising approach for identifying the subspecies
or genotypes of the M. abscessus group directly from
sputum samples.
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genotypes from DNA extracts of sputa samples using hsp65 PNA
real-time PCR. (DOCX 19 kb)
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